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Abstract
Islets of Langerhans are a pancreatic endocrine compartment consisting of insulin-producing b cells together with several
other hormone-producing cells. While some insulin-producing cells or immature pancreatic cells have been generated in
vitro from ES and iPS cells, islets with proper functions and a three-dimensional (3D) structure have never been successfully
produced. To test whether islets can be formed in vitro, we first examined the potential of mouse fetal pancreatic cells. We
found that E16.5 pancreatic cells, just before forming islets, were able to develop cell aggregates consisting of b cells
surrounded by glucagon-producing a cells, a structure similar to murine adult islets. Moreover, the transplantation of these
cells improved blood glucose levels in hyperglycemic mice. These results indicate that functional islets are formed in vitro
from fetal pancreatic cells at a specific developmental stage. By adopting these culture conditions to the differentiation of
mouse iPS cells, we developed a two-step system to generate islets, i.e. immature pancreatic cells were first produced from
iPS cells, and then transferred to culture conditions that allowed the formation of islets from fetal pancreatic cells. The islets
exhibited distinct 3D structural features similar to adult pancreatic islets and secreted insulin in response to glucose
concentrations. Transplantation of the islets improved blood glucose levels in hyperglycemic mice. In conclusion, the two-
step culture system allows the generation of functional islets with a 3D structure from iPS cells.
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Introduction
The pancreas consists of exocrine and endocrine compartments.
The endocrine compartment, known as islets of Langerhans, is
composed of several types of endocrine cells including, a, b, d, and
PP cells, which secrete glucagon, insulin, somatostatin, and
pancreatic polypeptide, respectively. The islet exhibits a unique
three-dimensional (3D) structure that differs between species.
Rodent islets are characterized by a spherical core of b cells
surrounded by a thin layer of non-b cells, which called mantle-
core, whereas a and b cells are in close contact throughout human
islets. During embryonic development, the expression of pancre-
atic proteins such as glucagon and amylase starts at around mouse
embryonic day (E) 13.5, followed by the expression of other
pancreatic proteins including insulin. Subsequently, distinct 3D
structures of islets and exocrine acini are formed, though it
remains unclear how such structures are formed. Neurogenin 3
(Ngn3) is an essential transcription factor for pancreatic develop-
ment and Ngn3-positive cells are considered as islet progenitors
[1]. Those cells are present in fetal pancreas but disappear
postnatally in normal development [2]. In experimental pancreatic
injuries, such as partial pancreatectomy or ablation of b cells in
adults, differentiated b cells proliferate to repair the damage [3].
Moreover, the number of pancreatic progenitors in the fetus
determines the size of the adult pancreas [4]. These results
together suggest that islet-genesis occurs only in the fetus.
Pancreatic islets play a central role in glycemic control. Type I
diabetes is a disease that destroys b cells resulting in insulin
deficiency, and patients with type I diabetes depend on the
administration of insulin for survival. However, fluctuations of
blood glucose levels can lead to complications and the transplan-
tation of islets is a promising therapeutic option for such patients.
With this protocol, islets isolated from donors are infused via the
portal vein. As the transplanted islets secrete insulin in response to
blood glucose levels, islets are a functional unit that can ectopically
regulate the blood glucose level [5]. However, donor shortage is a
major problem and a system of preparing a sufficient quantity of
functional islets is required. To this end, efforts have been made to
generate islets or b cells from various cell sources such as
pancreatic ducts and embryonic stem cells (ES) [6–12]. The
advent of induced pluripotent stem cell (iPS) technology has
further fueled these efforts. Although there are some reports of the
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28209development of insulin-producing cells in vitro, no functional islets
have ever been produced in vitro.
In organ culture of human fetal pancreas at 6–9 weeks of age, islets
were shown to develop ex vivo [13,14], suggesting that fetal pancreatic
cellshavethepotentialtoformisletsinvitro.In thispaperwe show that
islets are formed between E16.5 and E18.5 in mice, and that
cultivation of the pancreatic cells at E16.5 allows the formation of
functionalisletswith a structure similar toadultislets. By adopting this
culture system to immature pancreatic cells derived from mouse iPS
cells, we show that functional islets can be generated in vitro.
Materials and Methods
Mice
C57BL/6 and Akita mice were from Japan SLC, Inc. and bred
under specific pathogen-free conditions. The mice were main-
tained and mated in the institutional animal facility according to
the guidelines of the University of Tokyo. The experimental
procedures in this study were approved by the Committee for
Animal Experiments in the Institute of Molecular and Cellular
Biosciences University of Tokyo (approval number is 23003).
Antibodies
Primary antibodies used and dilutions were; guinea pig anti-
insulin (Dako, 1/200), rabbit anti-glucagon (Dako, 1/200), rabbit
anti-somatostatin (Dako, 1/200), rabbit anti-pancreatic polypep-
tide (Dako, 1/200), goat anti-C-peptide (Linco, 1/200), rabbit
anti-amylase (Sigma, 1/200), rabbit anti-CK19 [15,16], guinea pig
IgG isotype control (INTER-CELL TECHNOLOGIES INC,
1/200), and rabbit IgG isotype control (Vector, 1/200). The
secondary antibody used was biotinylated anti-guinea pig IgG
(Vector, 1/200). Thirdly antibodies used were; Alexaflour 488-
conjugated anti-rabbit IgG (Molecular Probes, 1/200), Alexaflour
555 anti-goat IgG (Molecular Probes, 1/200), and SA-conjugated
Alexafloura 594 (Molecular Probes, 1/200).
Preparation of Pancreatic Cells
Single-cell suspensions were prepared from the pancreata of
E14.5, E16.5, E18.5, neonate, P7, and adult mice. The pancreata
of the neonate, P7 and adult mice were carefully dissected under a
microscope and minced with scissors. Pancreatic tissues were
placed in Ca
2+-M g
2+- free PBS containing 2 mg/ml collagenase
type V (Sigma) and mixed by gentle pipetting every 3 minutes
during incubation for 10 min at 37uC. Digested pancreatic cells
were filtrated and washed in medium containing 10% FCS before
the cultivation. Cell viability was greater than 90% (fetal, neonate)
or 70% (P7, adult) as assessed by trypan blue dye exclusion.
Pancreatic Cell Culture
Digested pancreatic cells were seeded on a gelatin-coated 6-well
plate at 5610
4 cells/cm
2. Our standard culture medium is a 1:1
mixture of Dulbecco’s modified Eagle’s medium and F-12 (Gibco)
with 5% fetal bovine serum (Gibco), Nicotinamide (10 mmol/l,
Sigma), b-mercaptoethenol (50 mmol/l, Sigma), HEPES (5 mmol/l,
Gibco), and Gentamycin (50 mg/ml, Sigma). At 24 h after seeding,
the medium was changed to the standard medium supplemented
with epidermal growth factor (EGF) (20 ng/ml, Peprotech),
glucagon-like peptide (GLP)-1 (10 ng/ml, Sigma), and c-insulin
(10 mM,Wako).Atday12ofculture,culturedcellswereusedforRT-
PCR analysis, histological analysis, and transplantation. For the
histological analysis of frozen sections and transplantation, cultured
cells were detached from the culture dish by pipetting with 2 mg/ml
collagenase type V/PBS, taking care not to disrupt the 3D structure
of islets and ducts formed in vitro.
iPS Cell Culture
iPS cells were maintained in a standard ES/iPS cell mainte-
nance medium, DMEM/F12 with 15% KSR and 200 U ESGRO
(mLIF), according to the protocol previously described [17]. iPS
cells were dissociated into single cells using TripLE (Invitrogen)
and plated on a gelatin-coated dish for 30 min to eliminate feeder
cells. After the plating was repeated, non-adherent cells were
harvested and seeded on a collagen type IV-coated dish (IWAKI)
to induce their differentiation into pancreatic cells. The differen-
tiation of iPS cells into pancreatic cells was performed as described
Figure 1. Formation of pancreatic islets and acini during
development. Immunohistochemical staining of frozen sections of
pancreatic tissues at E14.5 (A, E), E16.5 (B, F), E18.5 (C, G), and neonate
(D, H). (A–D) Glucagon (green) and insulin (red), (E–H) amylase (green)
and insulin (red) staining. Nuclei were stained with dapi. Bar=100 mm.
doi:10.1371/journal.pone.0028209.g001
Figure 2. Formation of islet-like spherical cell aggregates in
vitro. Pancreatic tissues were dissociated and cultured for 14 days. (A)
Numbers of islet-like spherical structures larger than about 20 mmi n
diameter formed from one animal. (B, C) Photomicrographs of the
cultured cells formed from pancreatic tissues at E16.5 (B) and E18.5 (C).
Bar=300 mm.
doi:10.1371/journal.pone.0028209.g002
Generation of Transplantable Islets In Vitro
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28209previously [18–20] with some arranges and modifications to
seeding density and duration of culture. Briefly, activin, retinoic
acid, bFGF, bFGF+Nicotinamide were added sequentially to iPS
cells (see Fig. S4). The pancreatic cells differentiated from iPS
cells were dispersed into a single cell suspension using 2 mg/ml
collagenase/PBS and then seeded onto a gelatin-coated dish to
induce the formation of islets with the protocol used for fetal
pancreatic cells described above.
Histology
Tissues, cultured cells, and transplanted kidneys were fixed in
4% (wt/vol) paraformaldehyde, and stained with antibodies as
described in the Antibodies section. Tissues were embedded in
OCT compound (Tissue-Tek), and frozen sections (8 mm) were
prepared. For frozen sections of cultured cells, the cells were
detached from a culture dish as a sheet using collagenase. The
detached cells were fixed and embedded in OCT compound.
Cell transplantation and glucose level
The blood glucose levels were measured under nonfasting
conditions and were about 250 mg/dL in normal mice by the
assay system we used. Hyperglycemia was induced in C57BL/6
mice by intraperitoneal administration of streptozocin (STZ)
(150 mg/kg, Sigma). One or two weeks after the injection of STZ,
blood glucose levels were measured and the mice showing
hyperglycemia, i.e. 400 to 500 mg/dL, were used for transplan-
tation. Cells were transplanted into the kidney capsule of
anesthetized recipient mice. Alternatively, hyperglycemic Akita
mice were used for transplantation. At the indicated time points
after transplantation, blood was drawn from the tail vein and the
blood glucose level was determined with a glucose meter according
to the manufacturer’s instructions (Roche Diagnostic). Three
months after transplantation, the kidney was subjected immuno-
staining. Transplantations were performed between 8–12 weeks of
age in both model mice.
Figure 3. Expression of pancreatic hormones in spherical cell aggregates. (A) Photomicrograph of islet-like SCAs. (B, C) Negative controls of
the staining for glucagon, somatostatin, and pancreatic polypeptide (B, green), and for insulin (C, red). (D–M) Staining of glucagon, somatostatin,
pancreatic polypeptide, and insulin; glucagon (D, green), somatostatin (G, green), pancreatic polypeptide (J, green), insulin (E, H, K, red), and C-
peptide (M, red). F, I, L are the merged image of D and E, G and H, J and K, respectively. (N–Q) Staining of a frozen section. Dapi (N, blue), glucagon
(O, green), insulin (P, red), and a merged view for N–P (Q). Bars=100 mm.
doi:10.1371/journal.pone.0028209.g003
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To exclude insulin added in the culture medium, cultured cells
were washed three times with PBS, and subsequently washed with
Krebs-Ringer buffer. Krebs-Ringer buffer with a low glucose
concentration (50 mg/dL) was added and the cells cultured for
30 min. This low glucose buffer was then collected, and the cells
washed with Krebs-Ringer buffer. Krebs-Ringer buffer with a high
glucose concentration (500 mg/dL) was added and the cells
cultured for 30 min. This high glucose buffer was also collected.
The collected buffers were used to measure insulin concentrations
by ELISA (Shibayagi) according to the manufacturer’s instruc-
tions.
Statistical analyses
Data presented are means 6 SEM from at least three
independent experiments. Statistical comparisons between two
experimental groups were made using Student’s paired t-test and P
values,0.05 were considered significant.
Results
Development of mouse pancreas and cultivation of fetal
pancreatic cells
We first investigated when islets are formed by immunostaining
the pancreas during mouse development. Several cells in the
pancreas at E14.5 expressed amylase, glucagon or insulin, but they
were scattered without forming a specific structure (Fig. 1).
Although insulin- and glucagon-producing cells at E16.5 were in
close contact, the typical islet structure was not yet formed.
Structures similar to islets in the adult pancreas were clearly
observed at E18.5. These results indicate that islets form between
E16.5 and E18.5.
To test whether islets can be formed in vitro, we cultured fetal
pancreatic cells at E16.5, just before islets develop in vivo, using a
previously reported culture medium for pancreatic cells [6]. We
found that E16.5 fetal pancreatic cells proliferated as a monolayer
and subsequently formed spherical cell aggregates (SCAs) of
heterogeneous size by day 12. We optimized the culture conditions
by changing growth factors, extracellular matrics (ECM), source of
the cells and so forth, and found that SCA formation was
significantly increased by addition of EGF (Fig. S1) but not
different between collagen and gelatin (data not shown). The fetal
pancreatic cell culture system (FPCS) is described in the
Materials and Methods. Notably, SCAs were most efficiently
formed from E16.5 pancreatic cells and less efficiently from E14.5
cells. By contrast, neither E18.5, neonate, nor adult pancreatic
cells formed the islet-like structure in FPCS (Fig. 2). These results
suggest that the islet-forming potential in vitro is present only
transiently in the fetal pancreas around E16.5, coinciding with our
immunostaining results in vivo, i.e. that islets are formed between
E16.5 and E18.5 (Fig. 1). These results are consistent with
previous reports in human pancreas [9,13,14].
Characterization of cell aggregates formed in vitro
To investigate whether SCAs formed in FPCS were indeed
pancreatic islets, we immunostained the cultured cells. Large SCAs
were positively stained for insulin, glucagon, somatostatin,
pancreatic polypeptide and also C-peptide (Fig. 3). Importantly,
insulin-producing cells were surrounded by glucagon-, somato-
statin-, or pancreatic polypeptide-producing cells, showing the
typical ‘‘mantle-core’’ structure of adult murine pancreatic islets.
In contrast, a majority of small SCAs, smaller than 20 mm,
produced insulin but not glucagon, similar to islets in adult
pancreas. In addition, the mRNA expression of ins1 (data not
shown) and C-peptide (Fig. 3 M) in cultured fetal pancreatic cells
indicated that the insulin we detected by immunostaining was in
fact produced from the cells in SCAs, and not by the absorption of
insulin in the culture medium [21–25]. By contrast, no acinus-like
structure was found in E16.5 cultures, though there were some
amylase-producing cells (Fig. S2).
Glycemic control by cultured pancreatic cells
To evaluate the in vivo function of the islets formed in vitro,w e
transplanted them into the kidney capsule of mice with
Figure 4. Transplantation of islets formed in vitro. (A) Blood glucose levels of the hyperglycemic mice transplanted with E16.5 fetal pancreatic
cells (blue) or cultured cells (red). Immunostaining of frozen sections of the kidney 3 months after the transplantation; (B) Glucagon (green), insulin
(red), and dapi (blue). Bar=100 mm( C–F) High magnification of (B). Bar=20 mm.
doi:10.1371/journal.pone.0028209.g004
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proved soon after the transplantation of cultured pancreatic cells,
whereas the transplantation of fetal pancreatic cells without
cultivation in FPCS failed to reduce the glucose levels (Fig. 4
A). Thus, the formation of islets in FPCS is necessary for fetal
pancreatic cells to function in vivo.
To examine the fate of transplanted islets, we immunostained
frozen sections of the recipient kidneys three months after the
transplantation (Fig. 4 B–F). There were many SCAs in which
insulin-producing cells were surrounded by glucagon-producing
cells, indicating that islets were maintained in the kidney capsule
for at least three months. Notably, no tumor-like structures were
found in our experiments. Based on these structural and functional
characteristics, we conclude that functional and transplantable
islets can be produced in vitro from fetal pancreatic cells obtained
just before islets form in vivo.
Generation of islets from mouse iPS cells
Previous studies showed that ES cells could be converted in vitro
to pancreatic hormone-expressing cells [8–10]. Those cells formed
islet-like clusters a few months after their transplantation into mice
[9]. However, islets have never been produced in vitro from ES/iPS
cells. We therefore considered that the application of FPCS to
pancreatic immature cells derived from ES or iPS cells might allow
the generation of islets in vitro (Fig. S4). To test this possibility, we
first produced pancreatic cells from either mouse ES or iPS cells
according to the modified protocol of previously reported [18–20].
We confirmed that although there were some insulin- and/or
glucagon- expressing cells scattered in the culture at this point,
SCAs were not formed (Fig. 5 A–D).
Thereafter, we transferred the cultured cells into FPCS to
further induce differentiation and the formation of islets. SCAs
were formed at 14 days after replating in FPCS, similar to fetal
pancreatic cells. We optimized the culture conditions and found
that the formation of islets was dependent on the timing of the
replating and plating cell density (Fig. S3). Typically, 65676401
large SCAs and numerous small cell clusters were formed in one
well of a 6-well-plate. Immunostaining revealed that the large
SCAs expressed insulin and glucagon, showing the islet-like 3D
mantle-core structure (Fig. 5 E–J, N). The small cell clusters
expressed only insulin, similar to those formed from fetal
pancreatic cells (Fig. 5K–M). Basically the same results were
obtained using mouse ES or iPS cells.
Function of islets derived from mouse iPS cells
To evaluate the function of these islets in vitro, iPS-derived cells
were challenged with glucose before or after cultivation in FPCS
(Fig. 5 O). Although cells in both conditions secreted insulin at a
very low level at the low glucose concentration, the cells cultured
in FPCS with the high glucose concentration secreted about 8
times more insulin. These results indicate that cultivation in FPCS
confers on the iPS-derived pancreatic cells the ability to secrete
insulin in response to the glucose concentration.
Furthermore, the transplantation of iPS-derived cells in the
kidney capsules of hyperglycemic Akita mice quickly reduced
blood glucose levels and maintained the low glucose levels at least
10 weeks (Fig. 6 A, B). Typically at 9 days after transplantation,
the blood glucose levels were reduced to about 300 mg/dL which
is close to those in WT littermate mice, i.e. 257.9611.4 mg/dL
under nonfasting conditions (n=10) (Fig. 6 A, B). Histochemical
analysis revealed islet-like structures to be present in the kidney
capsules three months after transplantation (Fig. 6 C–G),
indicating that iPS-derived islets can be maintained long term.
In addition, no tumor was found in the transplanted mice. Taken
together, our culture system allows the generation of functional
islets with a unique 3D structure from both fetal pancreatic cells
and miPS cells (Fig. S4).
Discussion
We show in this paper that islets can be formed in vitro from fetal
pancreatic cells and iPS cells. The islets exhibit a mantle-core
structure, i.e. insulin-producing cells surrounded by glucagon-
producing cells, a distinctive feature of murine pancreatic islets.
Islets formed in vitro secrete insulin in response to the glucose
concentration, and improve hyperglycemia when transplanted in
the kidney capsules of hyperglycemic mice. Although there are
several reports describing the differentiation of pancreatic
hormone-producing cells from ES cells as well as other cell
sources [6–12], to our knowledge this is the first report showing the
generation of functional islets with the proper 3D structure in vitro
Figure 5. Formation of islets from miPS cells. (A–D) Immuno-
staining of pancreatic cells from miPS cells just before cultivation in
FPCS. Insulin (B, red), glucagon, somatostatin, and pancreatic polypep-
tide (C, green), dapi (D, blue) and a merged image (A). (E–N)
Immunostaining of large (E–G), medium (H–J, N), and small (K–M)
islets formed from miPS cells. Glucagon, somatostatin, and pancreatic
polypeptide (G, J, M, green), insulin (F, I, L, red), C-peptide (N, red).
Merged images of F, G and I, J and L, M are shown as (E, H, K)
respectively. Bar=100 mm( O) Secretion of insulin before (white) and
after (gray) cultivation in the presence of high (500 mg/dL) and low
(50 mg/dL) concentrations of glucose. Data presented are means 6
SEM (N=3). Similar results were obtained in three independent
experiments.
doi:10.1371/journal.pone.0028209.g005
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generation of islets in vitro from iPS cells paves the way to providing
a sufficient quantity of islets for clinical application.
Previous studies showed that there are common progenitors for
endocrine and exocrine cells in E11.5 pancreatic tissues [4], and
that islet-like structures developed in organ cultures of E11.5
pancreas [26–28]. In our culture, islets were formed most
efficiently from E16.5 pancreatic tissues and much less efficiently
from E14.5 pancreas, however no islet-like structure was formed
from E12.5 and E18.5 pancreatic tissues. These results suggest that
the endocrine progenitors rather than common progenitors are
responsible for the islet-forming potential in FPCS.
The number of progenitors in the fetal pancreas determines the
size of the adult pancreas [4]. It has been estimated that there are
about 2,500 islets including insulin-producing small cell clusters in
the adult pancreas of a C57BL/6 mouse [29,30]. In FPCS,
499636.3 islets together with many small cell clusters were formed
from a single embryo at E16.5, indicating that the efficiency is
reasonably high. However, it still remains unclear whether the
number of islets formed in FPCS directly correlates with the
number of islet progenitors. As fetal pancreatic tissues were
dispersed before the culture and islets were formed in vitro in a cell
density-dependent manner, islets may be produced by the
assembly of immature endocrine cells [31] rather than from a
single progenitor cell. While the precise nature of the islet
progenitor remains unknown, the culture system will provide a
means to characterize the progenitors.
An interesting and important finding in this paper is that there is
a critical window of time that allows the formation of 3D islet
structures in vitro. By adopting FPCS to pancreatic cells at the
appropriate stage of differentiation from iPS/ES cells, functional
islets were developed in vitro. Previous reports showed that by the
sequential addition of Activin/Wnt3, FGF, and FGF/Noggin/
cyclopamin, human ES cells were converted to insulin-producing
cells without showing any islet-like structures [8], likely corre-
sponding to the pancreatic cells at 6–9 weeks of age [32,33]. The
human fetal pancreas at this age is probably equivalent to an
E14.5–16.5 mouse pancreas, which contains only a few hormone-
expressing cells that do not respond to glucose [34]. Although
pancreatic cells derived from ES cells did not form any islet-like
structures in vitro, functional islets were formed in kidney capsules
of immune-deficient mice several months after the transplantation
[9]. Taken together, it is suggested that there is a critical window
of time for pancreatic cells, just before islet-genesis, to form islets in
vitro. Our results using mouse iPS cells are consistent with these
studies, however, they are significantly different from previous
reports because islet-like structures are formed in our culture
system and those cells produce insulin in response to glucose.
Furthermore, the transplantation of those cells immediately
improved the blood glucose level in hyperglycermic mice. In
conclusion, by applying FPCS to iPS-derived immature pancreatic
cells, transplantable islets can be generated in vitro.
Supporting Information
Figure S1 Effect of growth factor in islet formation in
vitro. Effect of growth factors for islet formation. EGF is the only
effective factor for islet formation within all growth factors and
cytokines we have. However, insulin and GLP-1 has a potential to
stabilize the culture, we use the combination of EGF, insulin, and
GLP-1. * significantly different. (p,0.05).
(TIF)
Figure S2 Acini were not formed in this culture system.
(A–C) Amylase staining (B, green), Dapi staining (A, blue), and
merged image (C)o f( A and B) of the multiple layers formed from
E16.5 pancreatic cells in vitro. Scale bars, 200 mm.
(TIF)
Figure S3 Timing and seeding density is important for
islet formation in vitro.A , Formation of islets at different
replating timing. The islet forming efficiency was higher at later
replating time points, however, we could not replate after 8 days in
the same condition (n=4). B, Islet forming frequency depends on
seeding cell density. There is a very narrow window of islet
formation for forming islets at high efficiently.
(TIF)
Figure S4 Diagram of the culture system for producing
islets from iPS cells. Islets are formed in vitro from pancreatic
Figure 6. Transplantation of islets formed from miPS cells. (A, B) Blood glucose levels of the Akita mice transplanted with islets formed from
miPS cells (A; glucose levels were measured for 10 days n=7, B; glucose levels were measuered for 10 weeks n=9). (C–G) Immunostaining of frozen
sections of kidney three months after transplantation; (C–F) insulin (C, F, red) and glucagon, somatostatin, pancreatic polypeptide (D, F, green) and
dapi (E, F, blue). (G) Higher magnification of (F). Bar=100 mm.
doi:10.1371/journal.pone.0028209.g006
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PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28209tissues just before the islet formation in vivo. iPS cells are induced to
differentiate to pancreatic cells sequentially by activin, retinoic
acid, bFGF, bFGF+nicotinamide and those pancreatic cells are
then replated in culture medium that induces islet formation from
fetal pancreatic cells.
(TIF)
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